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INTRODUCTION 
· Rising costs ~ave changed man·• s ideals and eating habits. Plant 
ingredients , because of their relatively low costs, have been 
increasingly used as a substitute for animal proteins. If these 
plant ingredients could be directly utilized by man, this would be a 
more efficient use of energy and nutrients. One plant source 
currently used i n such a manner is soybeans, which is a prime source 
of protein for human and livestock nutrition. However, soybeans 
contain several factors that are detrimental to man and livestock. 
Heating of. soybeans ~ounteracts these factors, since the undesirable 
factors are heat labile. However, heat alters the protein's 
properties making t hem unsuitable for many food products and calf 
milk replacers . Consequently, soybean processors currently use little 
or no heat in the production of soybean "isolates" and "concentrates." 
In their process, they discard, as waste, the soybean whey fraction. 
This fraction contains the toxic factors, but also usable protein and 
carbohydrate material. · Such a practice wastes 20% of the soybean 
protein in addition to adding to today's ever pressing pollution 
problem. 
The purpose of this research project was to further isolate 
and purify a small molecular weight growth inhibitor from soybeans 
and to gain needed knowledge about its properties. Once this growth 
inhibitor is identified, appropriate methods of inactivating or 
removtng the inhibitor may be developed, .so that much, if not all 
of the soybean whey proteins may be used beneficially for mankind. 
2 
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LITERATURE REVIEW 
More than 50 yea:rs have: passed since Osborne and Mendel (47) 
.reported the improved growth-promoting property of cooked versus raw 
soybeans. The explanation for this fact still remains unclear. 
Numerous studies and improved technology have only increased the 
complexity of the problem. Many factors have been implicated as the 
cause for the growth inhibition associated with raw soybeans, and 
these will be discussed in the following pages. 
Trypsin inhibitors. The finding (22) of a trypsin inhibitor 
in soybeans appeared -to explain the cause of the growth depression 
found when feeding raw soybeans. Westfall et al. (64) further 
substantiated this finding, when they found that the activity of this 
inhibitor was destroyed by autoclaving. This concept was supported 
when a crude trypsin inhibitor preparation was added to a heated 
soybean ration and reduced growth rates in chicks (23) and rats (30) 
resulted. Because of these results, trypsin inhibitors have received 
the majority of the attention in investigations designed to find the 
cause of growth depression by raw soybeans. 
Kunitz (31) first isolated a crystalline globulin protein from 
raw soybeans which forms, instantaneously, an irreversible 
stoichiometric compound with trypsin (20, 35, 57). When this trypsin 
inhibitor is denatured, it can be readily digested by pepsin (32). 
Even the undenatured form is slowly digested by pepsin (28). To date 
nine trypsin inhibitors have been isolated from soybeans (4o). These 
4 
inhibitors vary in size from 8,000 (16) to 24,000 molecular weight (32) 
and in other physical and chemical properties. Commercially available 
soybean trypsin inhibitors are usually the Kunitz inhibitor (31). 
· Crystalline soybean trypsin inhibitor, when added to 
chick (17, 19) and rat (19, 21) diets, depressed growth but never to 
the extent found when raw soybean meal (RSBM) was fed. When the soy-
bean whey fraction· was separated into two fractions, one fraction 
high in trypsin inhibitor activity and the other high in 
1hemagglutinating activity, · the ~ombination of the two fractions 
inhibited chick growth rates to a greater extent than either fraction 
alone (17). The soybean whey fraction contains trypsin inhibitors, 
hemagglutinins and unidentified components (14, 50, 51). Adding a 
potent trypsin inhibitor, p-aminobenzamidine, to the drinking water 
of rats caused growth depression, but reduced feed intake probably 
caused most of the growth depression (18). 
Borchers and Ackerson (9) and Brambila (10) proposed that the 
depressed growth assessed to trypsin inhibitors could be compensated 
by adding trypsin to the ration and thus tie up the soybean trypsin 
inhibitors with exogenous trypsin. However, the addition of trypsin 
to RSBM diets fed to rats (9) and chicks (10) could not overcome the 
growth-depressing effect of RSBM. 
Another approach was based on the hypothesis that if feeding 
RSBM caused interference of the enzymatic digestion in the small 
intestine and therefore caused growth depression, supplementing amino 
\ 
'-..__/ 
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acids should correct the growth depression (44). Some researchers 
(2, 7, 8, 9) felt they could raise the biological value of raw soy-
beans by supplementing the sulfur-containing amino acids instead of 
feeding intact proteins. This appeared to be a reasonable assumption 
because soybeans are low in methionine (59), while trypsin contains 
a relatively high level of cystine (3) which is usually synthesized 
from methionine. However, methionine supplementation of RSBM diets 
never produced growth rates equal to those achieved on autoclaved 
soybean meal diets (3, 8). Additional support for these results can 
be gathered from the research (24) that the supplementation of~ 
RSBM diet with= 11 amino acids required by chicks did not improve 
growth rates. Replacement of the RSBM by heated soybean meal 
resulted in substantially increased weight gains. Borchers (7) first 
found that supplementation of amino acids could alleviate the growth 
depression found when RSBM was fed, but later concluded that amino 
acid supplementation could produce only 75% the growth rate of the 
rats fed heated soybean meal diets (8). The addition of amino acids 
to the diet should have compensated for all the growth depression if 
trypsin inhibitors were the sole cause of growth depression. 
The ability of the animal to secrete extra enzymes as 
compensation for trypsin inhibitors in the diet (56) also indicates 
that trypsin inhibition was not the growth depressant. Even with 95% 
of the pancreas removed, there was no reduction in nitrogen digestion 
and absorption in rats as measured by fecal excretion (56). Protein 
digestion was only reduced when 99.5% of the pancreas was removed. 
6 
Schi ngoet he et al. (54), using a Sephadex G-50 column, 
separated a small molecular weight gtowth inhibitor from trypsin 
inhibitors. Hal f of the growth inhibition attributed to the soybean 
whey fraction was caused by the small molecular inhibitor, but caused 
no pancreas enlargement. 
Finall y, germinated soybeans had a protein efficiency ratio 
almost equal t o tnat of heated meal (15), but much higher than raw 
soybeans. The higher protein efficiency value with germinated 
: soybeans occurred even though there was no reduction in trypsin 
inhibitor concentration (13). 
Hemaggluti nins. Besides the antitryptic factor, hemagglutinins 
in raw soybeans have been incriminated as the growth depression 
factor. Hemagglutinating agents have been known to be present in 
plants since the 1880's (39). Hemagglutinin extracts from different 
seeds agglut inate t he red blood cells from some species of animals 
but not the cel ls from other species (4, 34, 42). Liener and co-
workers (41) had diffi~ulty correlating growth inhibition and 
trypsin inhibitor ac t ivity when feeding a diet containing a protein 
hydrolysate along with an antitryptic factor. They suggested the 
presence of some substance other than the antitryptic factor which 
adversely affects growth. Further investigation by Liener and 
Pallansch (42) resulted in the isolation of a homogeneous protein 
high in hemagglutinin activity. Additional purification indicated 
it had a molecular weight of 96,000 and contained 6-10% 
glucosamine ( 61) • _ / 
7' 
Evidence that the hemagglutinins may be responsible for the 
growt~-inhibiting properties of soyqeans has been minimal. 
Intraperitoneal injections of hemagglutinin preparations were lethal 
to young rats (37). However, physiologically this information is 
questionable because hemagglutinins are readily inactivated by peptic 
digestion when as few as 12% of the peptide bonds are split (38, 6). 
This should result in complete or almost complete inactivation prior 
to entering the small intestine. Also it is unlikely that an intact 
/ protein of 96,000 molecular weight, even if it survived gastric 
digestion, could be absorbed from the gut. Wada et al. (61) found 
that as they i"ncreased the hemagglutinin activity during the 
purification procedure there was only a slight increase in toxicity. 
When the hemagglutinin-containing fraction of soybean whey was 
separated from trypsin inhibitors and small molecular weight growth 
inhibitors by ion exclusion chromatography, very little growth 
inhibitor activity was found in the hemagglutinin fraction (54). 
Saponins. Sapoµins are glycosides which occur in a variety of 
plants. They are characterized by bitter taste, foaming in aqueous 
solutions and hemolyzing red blood cells. Upon complete hydrolysis 
they yield sapogenins and sugars. Proteolytic activity of trypsin 
was inhibited by high levels of soybean saponin (26). 
Since saponins interfered with proteolytic activity and caused 
· hemolysis of red blood cells, it was quite possible that saponins 
were the cause of the poor nutritive value of RSBM. Birk et al. (5) 
found that heat treatment had no effect on the hemolytic activity of 
8 
saponins. Since heat treatment of soybean m~al alleviates the growth 
depression, saponins ,must not be the ·growth-depressing factor. The 
.antiproteolytic activity was caused from a nonspecific reaction of 
saponins with protein an~ was readily counteracted by the presence of 
dietary proteins (26). 
Pancreatic enlargement. Feeding RSBM diets cause growth 
depression along with pancreas enlargement in chicks (11, 46, 53), 
rats (43, 48) and mice (54). Chernick et al. (11) found that chicks 
fed a RSBM diet had enlarged pancreases and suggested this was 
caused by the increased demand for trypsin which was met by increased 
secretion by the pancreas. The overall concentration of the 
proteolytic enzymes in. the pancreases of the chicks fed raw soybeans 
was unchanged, but with increased size of the organ the total activity 
was increased. 
This increase in size of pancreases has been attributed to 
levels of fat in diet (45), a factor in soybean hulls (58) and also 
trypsin inhibitors (43; 49). The pancreas enlargement produced by 
feeding raw soybeans has been suggested to be associated with growth 
depression, but there is no definite proof of the cause and effect. 
Kakade and co-workers (27) tested 104 varieties of soybeans and found 
a negative correlation (r = -.77) between pancreas size and protein 
efficiency ration when feeding raw soybean diets to rats. 
Schingoethe and Thomas (55), when feeding rats diets containing 
soybean trypsin inhibitors, found growth depression with only two of 
the four diets although all four diets caused pancreas enlargement. 
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The addition of soybean hulls to a purified ration caused pancreas 
enlar~ement with no growth depression. (58). Also, a growth inhibitor 
has been separated from soybeans that did not cause pancreas 
enlargement (54). 
wss of endogenous nitrogen. Because of increased enzyme 
production in animals fed a raw soybean diet, Lyman and Lepkovsky 
(43) felt that this could result in a large loss of endogenous 
nitrogen. The loss of nitrogen via this route could possibly account 
for some of the growth depression attributed to raw soybeans. This 
suggestion was further s~bstantiated when rats fed heated meal had 
lower proteolytic activity in their feces than rats fed unheated 
meal (36). Other researchers (12, 21, 29, 55) found increased 
proteolytic activity and increased trichloroacetic acid-insoluble 
protein in the intestinal contents of rats fed RSBM or diets 
containing soybean trypsin inhibitors. 
However, Kwong et al. (33) doubt whether this endogenous loss 
of nitrogen accounts for the growth depression found when feeding raw 
soybeans. They found no decrease in the percentage of nitrogen 
absorbed in rats fed a diet of unheated flakes starting at 25% and 
increasing to 75% of the total diet. Others (55) observed that 
despite the increased intestinal proteolysis on four trypsin inhibitor-
containing diets, rat growth rates were reduced on only two of the 
diets. 
Amino acid deficiency. Little agreement is found as to the 
extent amino acid supplementation will improve the nutritive value 
of RSBM diets. Adding methionine to a RSBM diet did not completely 
compensate for the growth depression .(2, _8). Borchers (7) claimed 
10 
that adding methionine to a RSBM diet could completely counteract the 
'growt~ depression. However, the weight gains (4.0 g/day) of these rats 
were much less than gains (6.5 g/day) of rats fed by Barnes et al. (2). 
They found that added methionine could account for only 75% of the 
growth depression attributed to RSBM. The differences in growth, rates 
could be attributed to the protein levels in the diets. Borchers fed 
a low protein diet (15%) compared to the diets (20% to 35% protein) 
fed by Barnes et al. (2). The lower protein diets may have been 
deficient in ~ethionine, and the added methionine would show more 
response in the lower protein diet. In later studies, Borchers (8) 
could attain only 75% of the growth of rats fed the heated soybean 
diet. Barnes et al. (2) suggested that supplemental methionine would 
increase growth rates of rats receiving low levels of heated or 
. 
unheated soybean preparations because methionine is the most limiting 
amino acid in soybeans. However, high levels of heated soybean meal 
provided the needed methionine and supplemental methionine showed no 
increased response. 
Supplementation of eight amino acids to a RSBM diet equaled 
the growth rate of the,heated soybean meal diet (7). Again, because 
of the lower protein content in the diet, the growth rates were not 
as high as those attained by the rats fed by Barnes et al. (2). 
However, there is no agreement among different investigators as to 
whether the addition of amino acids would make the protein present 
in raw soybean meal equivalent biologically to that of heated meal, 
or simply substitute for the protein~s deficiencies. 
11 
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MATERIALS AND METHODS 
Preparation of soybean meal fractions. Raw soybean meal 
(RSBM) was prepared by grinding and hexane-extracting soybeans (Corsey 
variety) as previously described by Schingoethe et al. (54). 
Heated raw soybean meal (HRSBM) was prepared by autoclaving raw 
meal according to procedures outlined by Renner and Hill (52). This 
procedure was modified slightly, in that the meal was autoclaved at 
110 C (15 lb steam pressure) for 15 minutes. After autoclaving the 
meal, it was air dried at room temperature and finely ground. 
One hundred grams of RSBM was extracted with one liter of 
distilled water for two hours at room temperature. During the 
extraction, the RSBM was slowly agitated with a magnetic stirr~r and 
then centrifuged (5,000 revolutions per minute for 10 minutes) to 
remove the water insoluble portion. After pouring off the supernatant, 
the meal was re-extracted with 500 ml of distilled water for one hour 
and centrifuged. The resulting supernatants were combined, acidified 
to pH 4.4 with 6N HCl (remove the acid insoluble proteins) and 
centrifuged. After lyophilizing1 , the pH 4.4 supernatant (pH 4.4-S) 
was stored for later use. 
Ion exclusion chromatography. Ion exclusion chromatography was 
employed in an attemp~ to further purify and separate the growth 
inhibitor (s). Experimentation with Sephadex G-25, G-15 and G-10 
1Virtis Research Equipment, New York. 
columns indicated that the G-25 column gave the most desirable 
separation. With an exclusion limit . of 5,000 molecular weight (MW) 
for proteins_, the trypsin inhibitors of 8,000 MW (16) to 24,000 MW 
(31) and hemagglutinins of 96,000 MW (61) would not be retarded, and 
would elute with the void volume. The growth inhibitor (s) isolated 
by Schingoethe et al. (54) would be slightly retarded. 
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Lyophilized.pH 4.4-S (2.25g) was redissolved in 75 ml of 
distilled water and applied to the Sephadex G-25 column (5.7 x 107 cm), 
,i' which was moni tared by a record.ing spectrophotometer at 280 nm. The 
pH 4.4-S was eluted with distilled water at 23 ml/minute. The effluent 
was collected :in 23 ml aliquots and every other tube assayed for 
trypsin inhibitor activity (25), protein (62, 63) and carbohydrate 
concentration (1). Approximately 20 runs were required to recover 
enough material for one mouse growth assay. 
Charcoal fractionation. Figure 1 shows the fractionation scheme 
that was employed using activated charcoal. 1 The pH 4.4-S was used as 
the starting material and mixed thoroughly with the activated charcoal 
prior to filtering. The resulting filtrate (char filtrate) was saved. 
The charcoal and adsorbed material was then washed with pH 11.5 NaOH, 
pH . 8.0 NaOH and pH 2.5 HCl and each of the resulting filtrates were 
saved. Volumes of filtrates were approximately equal to the amount of 
liquid that was used to wash the charcoal. Samples were taken from 
1Mallinckrodt Chemical Works, St. Louis, Missouri. 
27428 
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CHARCOAL FRACTIONATION 
pH 4.4·-S 
CHAR FILTRATE 
pH 11.5 FILTRATE 
1.2 L 
RESIDUE on CHARCOAL 
1 L pH 11.5 
(0.3N NaOH) 
RESIDUE on CHARCOAL 
1 L pH 8.0 
(0-15N NaOH) -_________ ____....._ 
pH 8.0 FILTRATE RESIDUE on CHARCOAL 
1 L . pH 2.5 
(02N HCL) ~---------_____.---
pH 2.5 FILTRATE CH ARCO AL DISCARDED · 
Figure 1. Fractionation of the pH 4.4 supernatant using activated 
charcoal as a crude ion exchange bed. 
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each of the filtrates and analyzed for trypsin inhibitor activity (25), 
protein (62, 63) and carbohydrate concentration (1) prior to 
lyophilizing. The pH 11.5 filtrate was the only filtrate neutralized 
to pH 7.0 with 6N HCl. 
Growth assay procedure. The test diet composition is shown in 
table 1. The soybean meal was HRSBM except for the RSBM and Y2HRSBM-
1/2RSBM diets, in which case RSBM replaced HRSBM and served as negative 
control diets. Part of the HRSBM was replaced in the diet by one of 
the various test fractions. The test fractions were added to the 
diets in amounts equivalent to the quantity recovered from 100 g of 
RSBM. To adjust for the loss incurred during fractionation, two times 
this amount was added to the various diets. 
Weanling mice were used as the test animal since Schingoethe 
et al. (54) found that mice gave a similar response to that of weanling 
rats but required less feed. Dietary treatment differences were 
observed at three days during the assay period, but most assays were 
run for five days. Tw~nty-one day old male mice were randomly 
assigned to the various diets and divided into subgroups. Usually 
eight to ten mice were used per ' treatment with four to five mice in 
each wire meshed cage. Beginning, three-day and terminating weights 
were recorded. On th~ fifth day the mice were sacrificed and 
pancreases removed and weighed. Feed intake for each treatment 
subgroup was determined by weighing the feed fed along with estimating 
feed in the feeders at termination of the experiment. A positive 
Table 1. Composition of Diets Fed to Mice 
Ingredient 
Salt mix1 
V·t . . 2 1. am1.n mix 
Corn oil 
a - Cellulose3 
4 Glucose 
. 6 Soybean meal test fraction 
Amount 
g 
4.o 
2.2 
5.0 
1.5 
37.3 
50-X 
X 
100.0 
1wesson modification of Osborne-Mendel Formula, 
Nutritional Biochemicals Corporation, Cleveland, 
Ohio. 
2vitamin diet fortification mixture, Nutritional 
Biochemicals Corporation, Cleveland, Ohio. 3Nutritional Biochemicals Corporation, Cleveland, 
4ohio. Dextrose, J. T. Baker Chemical Corporation, 
Phillipsburg, New Jersey. 
5soybean meal is HRSBM in all cases except for 
6raw soybean meal fraction. Soybean meal fractions replaced part of the 
HRSBM. 
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control (HRSBM) along with two negative controls (RSBM or YiliRSBM-
1/2.RSBM .and pH 4.4-S) were fed during each ·mouse growth assay to serve 
as controls tor that particular trial. 
17 
Growth inhibitor (GI) activity was calculated by the following 
formulas as prepared by Schingoethe et al. (54): 
1) Total GI activity (units)= 
(wt gain HRSBM - wt gain test) (feed intake test) 
-----,---------.------------ X 100 (wt gain HRSBM) (feed intake HRSBM) 
; 2) Specific GI activity (units/g) = 
(wt gain HRSBM - wt gain test) 1 100 X ------,.---------.--- X --------- X · 1 (wt gain HRSBM) (feed intake HRSBM) (xg test) 
One unit of GI activity equals 1% reduction in growth rate compared t o 
the positive control. Specific GI activity takes into account the 
amount of test fraction in the diet. Differences in feed intake were 
negligible except for the RSBM, Y2HRSBM-Y2RSBM and pH 4.4-S diets 
(Appendix tables 1-7). 
Enzyme inhibito+ assay. Trypsin inhibitor activities of soybean 
meal and various fractions were determined by the measurement of the 
inhibition of hydrolysis of p-toluenesulfonyl-L-arginine methyl ester 
(TAME) 1 by trypsin (25). The inhibitor samples were diluted to insure 
that the assay mixture was not saturated by inhibitor. 
Carbohydrate concentration determination. Carbohydrate 
concentration was determined as outlined by Badin et al. (1) at 520 nm. 
1Nutritional Biochemicals Corporation, Cleveland, Ohio. 
Statistical analysis. The data from the various mouse growth 
assays were analyzed individually according to the procedures by 
Steele and Torrie (60). The statistical significance between the 
means was analyzed by Duncan's new multiple range test (60). 
18 
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RESULTS AND DISCUSSION 
S'eparation on ,Sephadex G-25 column. Figure 2 illustrates the 
elution pattern of the pH 4.4-S on th~ Sephadex G-25 column. Protein 
values were calculated by the methods of Waddell (62) and Warburg and 
Christian (63). Since absorbencies at 280 run are proportional to 
protein concentration, for expediency, the column runs were monitored 
at this reading. On the basis of protein determinations, the effluent 
was divided into five fractions and designated as fractions I, II, 
,' III, IV and V, respectively. 
Fraction I (Fig. 2) contained all of the trypsin inhibitors. 
Hemagglutinins were assumed to be present in fraction I (61), although 
hemagglutinin assays were not conducted. Chymotrypsin inhibitors 
presumably were also located in this fraction (54), since most trypsin 
inhibitors also inhibit chymotrypsin. However, the fractions were not 
analyzed for chymotrypsin inhibitor activity. Carbohydrates were 
eluted in the same area of fractions II and III (Fig. 2) and, thus, 
were not separated from proteins or with one distinct protein fraction 
by this method. Small molecular weight material was located in 
fractions IV and V (Fig. 2). 
Growth inhibitor assay results of feeding the various pH 4.4-S 
, 
fractions separated on the Sephadex G-25 column are shown in table 2. 
Weight gains (g/day) of mice fed fractions I and II were significantly 
different from the HRSBM diet (P<0.05), but were not significantly 
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Figure 2. Elution pat t er n of pH 4.4 supernatant on a Sephad ex· G-25 column. Column dimensions: 
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Table 2. Growth inhibitor assay of fractions of pH 4.4 supernatant 
separated on Sephadex G-25 column •. 
~est fraction 1 Weight Pancreas Growth Inhibitor
2 
gain size TA SA 
(g/day) (% bw) (units) ( uni ts/g) 
HRSBM o.82a, 3 0.69c 
y'£RSBM 1/2RSBM 4 
pH 4.4 - s5 
G-25-r6 
-0.24 d 
0.19c 
o.42bc 
1.01a 
o.95ab 
o.95ab 
130 
77 
50 
63 
97 
145 
860 
_190 
·30 
I 6 
G-25-II 
G-25-III6 
G-25-IV6 
G-25-V6 
sEtvi7 
0.30c 
o.79ab 
o.84a 
0.87a 
0.12 
. 
0.77b 
o.6oc 4 
o.64c 
0.67c 
0.06 
1All diets contained 50% autoclaved soybean meal (HRSBM); 
soybean test fractions replaced part of the HRSBM. Diets were 
2fed for five days. Growth inhibitor activity was expressed as total activity (TA) 
and specific activity (SA). 
3Figures in the same column followed by the same letter are not 
significantly different (P>0.05) using Duncan's new multiple 
4range test (60). One half of the soybean meal source in this diet was raw 
(unheated) soybean meal (RSBM) and one half HRSBM. 
5The amount recovered from extracting 100 g RSBM replaced part 
6of the HRSBM in a diet normally containing 100 g HRSBM. The amount recovered from extracting 200 g RSBM and added to a 
7
diet normally coµtaining 100 g HRSBM. 
Standard error of mean. 
different (P>o.05) than the pH 4.4-S diet. Fractions III, IV and V 
were not significantly different from the HRSBM diet (P>0.05). 
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Growth inhibition due to the fraction I diet could possibly be 
attributed to trypsin inhibitors or some other proteinaseous material 
with a molecular weight greater than 5,000 but less than 30,000. This 
seems to be a reasonable assumption since Schingoethe et al. (54) 
found little or no.GI activity in the fraction-containing protefns 
with molecular weights greater than 30,000. However, they found 
relatively the same amount of GI activity in their trypsin inhibitor-
containing fraction as was observed with fraction I. Also, 
crystalline trypsin inhibitor does not cause the extreme growth 
depression found when feeding RSBM (17, 19, 21). Fraction I had a 
very high specific GI activity (860 units/g) and caused pancreatic 
enlargement, 0.95% compared to 0.69°/4 for the HRSBM fed mice, when 
expressed as %-body weight. Total GI activity was divided into 
fractions I and II, with fraction II containing slightly more than 
half of the total GI aGtivity. The lower specific GI activity 
associated with fraction II was attributed to the extraneous material 
present in this fraction. A trace of GI activity was found in 
fraction III, which may have resulted from incomplete separation from 
fraction II. Fraction IV and V did not cause growth depression or 
pancreas enlargement. 
The retention of the growth inhibitor located in peak II on 
the Sephadex G-25 column indicated a small molecular weight material. 
Known molecular weight substances were eluted on the same Sephadex 
G-25 column (previously used for the separation of the pH 4.4-S) in 
an attempt to estimat'e the molecular weight of the growth inhibitor 
·located in peak II. Comparing the elution pattern of these known 
molecular weight substances to the elution pattern of the pH 4.4-S 
(Fig. 2), soybean trypsin inhibitor1 (24,000 MW) eluted off the same 
as peak I. GlucagQn2 (3,4oO MW) eluted off between peaks I and ~I, 
whereas tryptophan3 (200 MW) was eluted on the declining side of 
,peak III. Plotting log of molecular weight versus elution volume 
I 
indicated a molecular weight of 1,200 for peak II, 500 for peak III 
and molecular weights similar to those of smaller amino acids for 
peaks IV and V. 
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The data of four mouse growth assays (see Appendix tables 1-3 
for actual data), in which the various G-25 fractions were fed, are 
summarized in table 3. Growth depression was divided between fractions 
I and II, with fraction I causing pancreas enlargement as compared to 
the HRSBM diet. Fraction III had a higher GI activity than observed 
in table 2. This was probably due to poor separation from fraction 
II in initial column runs. Although total GI activity was about the 
1soybean trypsin inhibitor 5 X crystallized, Nutritional Biochemical 
2corporation, Clevelana, Ohio. 
3Nutritional Biochemical Corporation, Cleveland, Ohio. Eastman Organic Chemicals, Rochester, New York. 
Table 3. Growth Inhibitor and Pancreas Enlargement Activities of 
G-25 separated fractio.ns of pH 4.4 supernatant. (See 
Appendix tables 1-3 for actual data.) 
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1 2 Relative
3 
Test fraction Weight Growth Inhibitor pancreas 
gain TA SA size 
(g/day) (units) (units/g) (%) 
HRSBM 0.69 100 
Y2HRSBM - Y2RSBM4 -0.14 120 85 143 
pH 4~4 - s5 -0.10 114 200 131 
I 6 
G-25-I 0.23 67 913 144 
G-25-II 6 0.16 77 334 106 
G-25-III 6 o.45 35 170 100 
G-25-IV 6 0.78 . 98 
G-25-V 6 0.79 101 
1 
1' table 2. 2see footnote 
3
see footnote 2, 2. 
Pancreas wt. as wt. on test diet X 100 
4Pancreas wt. as 
0
~ body wt. on HRSBM 
5
see footnote 4, table 2. 
6see footnote 5, table 2. See footnote 6, table 2. 
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same in fractions I and II, - fraction I had a much higher specific GI 
activity. Protein fraction II had a lower specific GI activity than 
fraction I because of the high carbohydrate concentration present with 
the protein fraction. Fractions IV and V showed no GI activity, and 
fractions II, III, IV and V did not cause pancreas enlargement. 
Growth inhibition associated with fraction I was not separated 
from the trypsin inhibitors. However, until this fraction is further 
purified the growth depression may or may not be attributed to the 
trypsin inhibitors. Fraction II caused growth depression, was free of 
any trypsin inhibitors and did not cause pancreatic enlargement. 
Sharper separation between the trypsin inhibitors and small mol~cular 
weight growth inhibitor, than that reported by Schingoethe et al. (54), 
was accomplished by using the Sephadex G-25 column. However, since 
the specific GI activity attributed to this fraction was not as high 
as fraction I, more purification is needed to ascertain whether the 
carbohydrate material or other unidentified materials are contaminants 
or a cause of the growth inhibition. Because of the clear separation 
between fractions I and II, it was concluded that these were two 
different growth inhibitors. 
Separation by activated charcoal. In an attempt to separate 
the carbohydrate materjal from the protein fractions, a fractionation 
scheme (Fig. 1) was devised using activated charcoal as a crude ion 
exchange bed. If this system would separate the growth inhibitor from 
carbohydrates or from other materials, it could be readily applied on 
a commercial basis. 
After lyophilizing the various filtrates that resulted from 
charcoal fractionation, they were redissolved in distilled water and 
applied to t~e same Sephadex G-25 column that was used for the 
pH 4.4-S separation. This was done as a means of desalting and also 
to see if any separation had been achieved by this fractionation 
scheme. 
Figure 3 show~ the separation of the pH 4.4-S achieved by the 
activated charcoal fractionation. In comparing figures 2 and 3, 
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/peak I (Fig. 2) was located primarily in the charcoal filtrate (scan 
no.. 1, Fig. 3), which also had trypsin inhibitor activity and contained 
almost all of :the carbohydrate material that was recovered. The 
latter may be more clearly shown in table 4. The pH 11.5 filtrate 
(scan no. 2, Fig. 3) contained a small amount of peak I (Fig. 2) and 
predominantly peaks II and III (Fig. 2). The pH 11.5 filtrate 
contained small amounts of trypsin inhibitor activity and carbohydrate 
material (table 4). Peak II (Fig. 2) was the most abundant in the 
pH 8.0 filtrate (scan no. 3, Fig. 3) with no trypsin inhibitor 
activity and a very small amount of carbohydrate material (table 4). 
Scan 4 (Fig. 3) showed that a very minute amount of protein was 
recovered in the pH 2.5 filtrate. The protein present was primarily 
peak II (Fig. 2) components. Also, the carbohydrate concentration was 
low, with no trypsin inhibitor activity (table 4) being found. 
Table 4 also shows the dry matter recovered in the various 
freeze dried filtrates. Because of the added NaOH and HCl, the dry 
matter recovered from all of the filtrates was higher than that 
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Figure 3. Chromatography on Sephadex G-25 of charcoal filtrate fractions of pH 4. 4 supernatant . 
Charcoal filtrate , 1; pH 11.5 filtrate , 2 ; pH 8.o filtrate , 3; pH 2 . 5 fil trate , 4. 
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Table 4. Carbohydrate concentration, dry matter recovered and 
trypsin inhibitor activity in the various charcoal 
separated pH 4. 4-S filtrates . 
Filtrate Carbohydrate Dry Matter 1 Trypsin 
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2 
concentration inhibitor 
activity 
3 pH 4.4 - S 
Charcoal filtrate 
. 4 
pH 11.5 filtrate 
pH 8.o filtrate 
pH 2.5 filtrate 
1 
(µg/ml) 
965 
460 
58 
32 
22 
(g) 
21.0 + 
6.o + 
12.8 + 
4.8 
3.0 
Dry matter that was recovered from 100 g RSBM . 
~rypsin inhibitor activity was indicated as being present(+) 
or not present(-) in the various filtrates . 3This was the starting material for the charcoal fractionation 
scheme . This was analyzed to compare with the filtrates for 
4a~ounts recovered or lost during fractionation . This filtrate showed trypsin inhibitor activity if the 
filtrate was neutralized immediately to pH 7 .0 . 
Denaturation of proteins occurred if the filtrate was left 
at pH 11 . 5 . 
normally recovered from the freeze dried pH 4.4-S. Salt 
concentrations in the pH 11.5 and pH 8.o filtrates were 22% and 18%, 
respectively. After desalting, both contained 11% salt. 
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Data of four mouse growth assays in which the charcoal filtrates 
were utilized as the test diets are summarized in table 5 (see 
Appendix tables 4-7 for actual data). Although no large differences 
were found between the weight gains of the mice fed the various test 
diets and the HRSBM diets, the pH 8.0 filtrate had a high .GI activity 
with no pancreas enlargement. Since elution on Sephadex G-25 (Fig. 3) 
indicated that the pH 8.·o filtrate contained predominantly fractions 
II and III and no fraction I, growth inhibition was probably du~ to 
fraction II. However, because of the extreme pH changes, the proteins 
were denatured and thus decreased the growth inhibitor activity. 
Fractions II and III (pH 4.4-S separated on Sephadex G-25 
column) were coliected together and lyophilized. Thirty-five grams of 
fractions II and III (amount recovered from 25 column runs) were_ 
redissolved in one liter of distilled water and sent through the same 
fractionation scheme shown in figure 1. The procedure was modified 
slightly in t~at much weaker concentrations of base and acid were used. 
Approximately 23 grams of dry matter were recovered in all of the 
filtrates. 
Growth trial results from feeding the various filtrates of the 
charcoal fractionation of fractions II and III are shown in table 6 
(see Appendix table 4 for actual data). Growth inhibitor activity was 
Table 5. Growth assay by mice fed various fractions of pH 4.4 
supernatant eluted through Charcoal . (See Appendix 
tables 4-7 for actual 'data.) 
Test fraction 1 Growth Inhibitor2 
TA SA 
(units) (units/g) 
HRSBM 
1/2.HRSBM - 1/2RSBM4 120 85 
pH 4. 4 - S 5 114 201 
Charcoal filtrate6 19 33 
pH 11.5 filtrate6 6 7 
pH 8.0 
:6 
filtrate 25 350 
pH 2. 5 filtrate6 18 122 
1 footnote 1' table 2. 2see 
3see footnote 2, table 2. 
4see footnote 3, table 3 . 
5see footnote 4, table 2. 
6see footnote 5, table 2. See footnote 6, table 2. 
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Relative3 
pancreas 
size 
(%) 
100 
143 
131 
104 
98 
97 
93 
:':, t,lc 6. Growth assay by mice fed various fractions of G-25 
Fraction II and III eluted through Charcoal. (See 
Appendix table 4 for actual data.) 
1 ~:et 
~:RSBM - 1/2RSBM 
-:J 4.4 s4 
:-25 Fraction II and III 
Charcoal filtrate5 
pH 11.5 filtrate5 
pH 8.0 f:i.ltrate5 
pH 2.5 filtrate5 
Growth Inhibitor2 
TA SA 
(units) (units/g) 
120 
114 
17 
23 
27 
201 
39 
230 
1 2 
3
, See footnotes 1 and 2, table 2. 
4see footnote 3, table 3. 
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Relative3 
pancreas 
size 
(%) 
100 
143 
131 
96 
92 
104 
5see footnote 5, table 1. The amount r ecovered f r om 35 g, freeze dried fractions II and 
III, sent through charcoal fractionation. 
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again located in the pH 8.0 filtrate, substantiating results reported 
in table 5. The pH 11.5 filtrate contained the second highest GI 
activity with none of the filtrates causing pancreas enlargement. 
Although the small molecular weight growth inhibitor was in 
fractions II and III prior to sending it through the charcoal, very 
little of the growth depressant was recovered in the charcoal 
filtrates. Absence of the growth depression was attributed to the 
extreme pH changes, which caused denaturation of proteins. · 
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SUMMARY AND CONCLUSIONS 
Ion exclusion chromatography was employed to further purify and 
separate a small molecular weight growth inhibitor from soybean 
trypsin inhibitors. The pH 4.4-S was separated on a Sephadex G-25 
column into five fractions. Fraction I contained proteinaceous 
material greater than 5,000 molecular weight and trypsin inhibitor 
activity. Diets containing this fraction when fed to mice caused 
growth depression and pancreas enlargement. Growth depression was 
caused by fraction II diets, but no pancreas enlargement was noticed. 
The growth inhibitor present in fraction II was calculated to have a 
molecular weight of 1,200. The diets containing G-25 fractions III, 
IV and V caused little or no growth depression to mice and did not 
cause pancreas enlargement. Because of the clear separation 
accomplished between fractions I and II, with both causing growth 
depression and only fraction I causing pancreas enlargement, it was 
concluded that these are two different growth inhibitors present in 
the soybean whey fraction. The mechanism of the growth inhibition by 
these inhibitors may be different. 
Animal growth assays are the only positive measurement of the 
growth depressant in soybeans. However, this method involves a great 
deal of time in preparation of the fractions to be used in the diets. 
An attempt was made to batch separate the growth inhibitor from 
so~beans, utilizing activated charcoal as a crude ion exchange bed. 
In comparing this fractionation to the separation via the 
Sephadex G-25 column, preferential separation was achieved. However, 
the extreme pH changes employed, denatured the proteins and decreased 
the growth inhibitor (GI) activity of the various filtrates. 
Elimination of some of the carbohydrate material as the cause of the 
growth depression was accomplished by this fractionation. The pH 8.0 
filtrate had the highest GI activity of the various filtrates in most 
of the mouse growth assays. There are three possible explanations 
for this, and they are: 
1) Greater denaturation occurred at the pH extremes. 
2) G-25 peak II was the most prevalent in the pH 8.0 filtrate. 
3) The growth inhibitor may be active at pH 8.o and inactive 
at extreme pH's. 
The pH 8.0 filtrate caused growth inhibition even though it was almost 
void of G-25 pea~ I. However, it was concluded that because of the 
denaturation of proteins incurred during the fractionation, this 
method would possibly be better suited to detoxify the soybean whey 
fraction than to separate and purify the growth inhibitor. 
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APPENDIX 
Appendix Table I. Individual weight gains, pancreas size, feed 
intake and quantity of test fraction in various 
diets fed to mice. (Mouse growth assay No. 1. 
Diets fed for five days.) 
Test fraction 1 Weight Pancreas size Feed Test 
gain intake fraction 
in diet 
42 
2 
(g/day) (g) (% body wt) (g/day) (g/100 g diet) 
HRSBM 
1/2.HRSBM - 1/2RSBM 
pH 4._4 - S 
G-25 - r4 
G-25 - II & III 
G-25 IV & V 
SEM5 
o.78a, 3 
:...0.43c 
o.43b 
0.78a 
o.56ab 
0.71a 
0.09 
0.11 
0.14 
0.14 
0.13 
0.11 
0.12 
0.57c 4.8 50.0 
0.92a 2.5 25~0 
0.77b 4.4 7.0 
o.6$b 4.9 0.3 
o.64b 4.8 4.o 
o.63bc 4.9 0. ,1 
0.04 
1see text for complete description of test fractions. 
2iest fraction is equivalent to the quantity recovered from 
100 g RSBM except for HRSBM, 1/2HRSBM - 1/2RSBM. 
3Figures in the same column followed by the same letter are not 
significantly different (P>0.05) using Duncan's new multiple 
4range test (60). This fraction was concentrated in a Virtis freeze concentrator 
5
and probably denatured the proteins. (Only for this trial.) 
Standard error of mean. -
•. 
Appendix Table It. Individual weight gains, pancreas size, feed 
intake and quantity of test fraction in various 
diets fed to ·mice. (Mouse growth assay No. 2. 
Diets fed for three days.) 
Test fraction 1 Weight Pancreas size Feed Test 
gain intake fraction 
in diet 
43 
2 
(g,/da:y) (g) (% body wt) (g,/day) (g/100 g diet) 
HRSBM 
1/:iliRSBM - 1/2RSBM 
pH 4.4 - S 
IG-25 - I 
G-25 - II 
G-25 - III 
SEM4 
0.30a,3 
-0.66cd 
-0.91d 
-0.36bc 
-0.27b 
o.07ab 
0.09 
0.15 
0.16 
0.16 
• 0.19 
0.15 
0.14 
o.69bc 7.4 50.0 
o.83ab 5.1 25.0 
o.84a 7.3 10.0 
0.94a 6.3 1.5 
o.69bc 5.4 3.8 
0.67C 7.3 5.7 
0.04 
1see footnote 1 Appendix Table I. 
~est fraction is equivalent to 2 X the quantity recovered from 
31~0 g RSBM except HRSBM, 1/zHRSBM - 1/2.RSBM, and pH 4.4. ' See footnotes 3 and 5 Appendix Table I • 
•. 
Appendix Table III. Individual weight gains, pancreas size, feed 
intake and quantity of test fraction in various 
diets fed tb mice. (Mouse growth assay No. 3. 
Diets fed for five days.) 
Test fraction 1 Weight 
gain 
Pancreas size Feed 
intake 
Test 2 fraction 
in diet 
44 
(g,lday) (g) (% body wt) (g/day) (g/100 g diet) 
HRSBM 
1/.iliRSBM - 1/2.RSBM 
G-25 - I 
G-25 - II 
G-25 - III 
SEM4 
o.74a, 3 0.10 
. b 
-0.18 0.14 
0.50a 0.14 
o.46a 0.10 
0.50a 0.11 
0.09 
0.59c 
0.97a 
o.93ab 
0.65c 
o.68bc 
0.09 
~See footnote 1 Appendix Table I. 
3s~e footnote 2 Appendix Table II. 'See footnotes 3 and 5 Appendix Table I. 
7.25 
4.8 
4.o 
4.6 
5-5 
50.0 
25.b 
1.6 
3-9 
3-5 
Appendix Table IV. Individual weight gains, pancreas size, feed 
intake and quantity of test fraction in various 
diets fed to -mice. (Mouse growth assay No. 4. 
Diets fed for five days.) 
Test fraction 1 Weight 
gain 
Pancreas size Feed 
intake 
Test 2 fraction 
in diet 
45 
(g/day) (g) (% body wt) (g/day) (g/100 g diet) 
HRSBM 
1/2HRSBM - 1/2.RSBM 
pH 4.4 - S 
_I G-25 - I 
Charcoal filtrate 
: 4 
pH 11.5 filtrate 
o.75a, 3 0.11 
. C 6 -0.21 0.1 
-o.48c 0.12 
0.37a, b • 0.13 
0.24 b 0.11 
d -1.12 
pH 8.0 filtrate 0.03bc 0.09 
0.11 pH 2.5 filtrate 0.51a 
Charcoal G-25 
II & III filtrate 0.63a 0.10 
pH 11.5 G-25 
II & III filtrate 0.58a 0.09 
pH 8.0 G-25 
II & III filtrate 0.54a 0.11 
pH 2.5 G-25 
II & III filtrate 0.79a 0.11 
0.15 
1 
2see footnote 1 Appendix Table I. 
o.66c 
0.92a 
o.88ab 
o.64c 
0.61d 
0.67c 
0.04 
See footnote 2 Appendix Table II. 
'See footnote 3 Appendix Table I. 
Mice died before termination of experiment 
were used and pancreases were not weighed. 
5attribut-ed to high salt concentration. See footnote 5 Appendix Table I. 
6.3 
5.6 
3.5 
5.6 
4.5 
2.2 
4.6 
6.2 
5.6 
5.5 
6.3 
5.6 
50.0 
25.b 
10.0 
2.5 
8.8 
12.8-
5.2 
2.9 
6.8 
1.6 
o.8 
0.3 
so three day weights 
Death may be 
Appendix Table V. Individual weight gains, pancreas size, feed 
intake and quantity of test fraction in various 
diets fed to mice. (Mouse growth assay No. 5. 
Diets fed for five days.) 
Test fraction 1 Weight 
gain 
Pancreas size Feed 
intake 
Test 2 fraction 
in diet 
46 
(g/day) (g) (% body wt) (g/day) (g/100 g diet) 
HRSBM o.61a, 3 0.09 o.67ab 5.4 50.0 
1/2.HRSBM - 1/zRSBM 
pH 4.4 - S 
Charcoal filtrate 
pH 11.5 filtrate4 
pH 8.o filtrat~4 
HRSBM, pair fed5 
sni 
-0.07 b 
0.17b 
o.68a 
0.65a 
o.6oa 
0.57a 
0.12 
0.10 
0.10 
0.11 
0.09 
0.09 
0.09 
1 
2see footnote 1 Appendix Table I. 
o.86a 
0.81a 
0.75a 
0.61b 
0.61b 
0.59b 
0.06 
See footnote 2 Appendix Table II. 
'See footnote_ 3 Appendix Table I. 
NH40H used instead of NaOH and also at a ~Fed HRSBM equal to the charcoal filtrate 
See footnote 5 Appendix Table I. 
3.8 
2.7 
3-5 
5.7 
3.9 
3-5 
25.0 
10.0 
6.4 
2.4 
o.4_ 
50.0 
weaker concentration. 
diet. 
Appendix Table VI. Individual weight gains, pancreas size, feed 
intake and quantity of test fraction in various 
diets fed to mice. (Mouse growth assay No. 6. 
Diets fed for five days.) 
Test fraction 1 Weight 
gain 
Pancreas size Feed 
intake 
Test 2 fraction 
in diet 
47 
(g/day) (g) (% body wt) (g/day) (g/100 g diet) 
HRSBM 
1/iHRSBM - 1/2RSBM 
pH 4.4 s4 
Charcoal filtrate5 
. 6 
pH 11.5 filtrate 
pH 8.o filtrate6 
pH 11.5 filtrate7 
pH 8.0 filtrate? 
pH 11.5 filtrate 8 
pH 8.0 filtrate8 
15 .g Nac1 9 
';I) g Nac1 9 
SEM10 
o.98a, 3 0.10 
0.29cd 0.15 
0.54c 0.14 
o.46c 0.08 
1.19a 
o.86ab 
0.99a 
0.94a 
o.61bc 
0.15d 
0.09 
0.11 
0.09 
0.10 
0.82 
0.09 
0.07 
1 
2See footnote 1 Appendix Table I. 
0.56b 
0.92a 
0.85a 
0.52b 
0.63b 
0.57b 
0.54b 
0.53b 
0.58b 
0.53b 
0.04 
4.9 
4.o 
4.9 
4.6 
4.4 
4.6 
4.3 
3.8 
4.4 
4.4 
50.0 
. 25.0 
·B.o 
10.8 
4.o 
4.4 
1.3 
0.3 
2.1 
0.3 
6.o 
12.0 
See footnote 2 Appendix Table II. 
~See footnote 3 Appendix Table I. 
Diet was made up to 250 g instead of the usual 200 gin an. 
attempt and may be reason for higher gain/day. 
~Added to diet 5 X the normal rate recovered from 100 g RSBM. 
Ba(0H) 2 • 8H2o and ZnS04 used as basic and acidic reagents. ~ice died of zinc toxicity. 
8Ba(0H) 2 • 8H2o and H2so4 used as basic and acidic reagents. Na0H concentration was much weaker than used previously. 
9This was a higher level of salt than was present in pH 11.5 and 
10pH 8.0 filtrates, mouse growth assay No. 4 (Appendix Table IV). See footnote 5 Appendix Table I. 
48 
Appendix Table VII. Individual weight gains, pancreas size, feed 
intake and quantity of test fraction in various 
diets fed to ·mice. (Mouse growth assay No. 7. 
Diets fed for five days.) 
Test fraction1 
HRSBM 
1/MRSBM - 1/zRSBM 
pH 4.4 - S 
Charcoal filtrate 
pH 11.5 filtrate4 
:4 
pH 8 .O filtrate 
pH 11.5 filtrate5 
pH 8.0 filtrate5 
6 15 g NaC1 
6 30 g NaC1 
SEM7 
Weight 
gain 
(g/day) 
1.11a,3 
0.30b 
0.22b 
0.85a 
o.86a 
0.97a 
1.ooa 
1.02a 
0.81a 
0.10b 
0.11 
Pancreas size 
(g) (% body wt) 
0.11 0.55c 
0.16 0.95a 
0.12 0.81b 
0.10 0.52 C 
0.12 o.61c 
0.11 o.6oc 
0.09 0.51c 
0.10 0.53c 
0.04 
1 
2see footnote 1 Appendix Table I. 
Feed Test 
intake fraction2 
in diet 
(g/day) (g/100 g diet) 
4.8 50.0 
4.o 25.b 
4.2 10.0 
5-5 7.4 
4.8 6.4 
5-3 4.o -
4.5 4.5 
5-5 2.5 
4.8 6.o 
4.6 12.0 
See footnote 2 Appendix Table II. 
lsee footnote 3 Appendix Table I. 
Test fraction fed is half as much as fed in mouse growth assa:y 
No. 4 (Appendix Table IV). Not desalted. 
5Test fraction fed is half as much as fed in mouse growth assay 
No. 4 (Appendix Table IV). Desalted by eluting through Sephadex 
6G-25 column. Pancreases wer e n ot weighed because in a previous trial (Appendix 
Table VI), the pancreases had not been affected by the high salt 
7concentration. See footnote 5 Appendix Table I. 
